Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

New to the Game?

Current DHHS Treatment Guidelines for First Time Therapy*

March/April 2010

Patients naïve to antiretroviral therapy should be started on one of the following three types of combination regimens:

  • NNRTI + 2 NRTIs; or
  • PI (preferably boosted with ritonavir) + 2 NRTIs; or
  • INSTI + 2 NRTIs

Preferred Regimens
NNRTI-based Sustiva (efavirenz) 1 + Truvada (emtricitabine/tenofovir)
PI-based Boosted Reyataz (atazanavir/ritonavir) + Truvada (emtricitabine/tenofovir)
Boosted Prezista (darunavir/ritonavir) + Truvada (emtricitabine/tenofovir)
INSTI-based Isentress (raltegravir) + Truvada (emtricitabine/tenofovir)
Preferred for Pregnant Women
PI-based Kaletra (lopinavir/ritonavir) (twice daily) + Combivir (zidovudine/lamivudine)
Alternative Regimens
NNRTI-based Sustiva (EFV) + Epzicom or Combivir (ABC or ZDV)/3TC 3
Viramune (NVP) 2 + Combivir (ZDV/3TC) 3
PI-based Boosted Reyataz (atazanavir/ritonavir) + Epzicom or Combivir (ABC or ZDV)/3TC 3
Boosted Lexiva (FPV/r (once or twice daily) + either Epzicom or Combivir [(ABC or ZDV)/3TC 3] or Truvada (emtricitabine/tenofovir) 3
Kaletra (LPV/r) (once or twice daily) + either Epzicom or Combivir [(ABC or ZDV)/3TC 3] or Truvada (emtricitabine/tenofovir) 3
Boosted Invirase (SQV/r) + Truvada (emtricitabine/tenofovir) 3

Visit www.aidsinfo.nih.gov for the complete set of guidelines and for more detailed information, including "acceptable regimens," "regimens that may be acceptable, but more definitive data are needed," and "regimens to be used with caution."

  1. Except during first trimester of pregnancy or in women with high pregnancy potential
  2. Viramune (nevirapine) should not be initiated in women with CD4+ T-cell count greater than 250 cells/mm3 or in men with CD4+ T-cell count greater than 400 cells/mm3
  3. Emtriva (emtricitabine) and Epivir (lamivudine) are interchangeable

Abbreviations: INSTI = integrase strand transfer inhibitor, NNRTI = non-nucleoside reverse transcriptase inhibitor, NRTI = nucleos(t)ide reverse transcriptase inhibitor, PI = protease inhibitor
ABC = abacavir, ATV = atazanavir, 3TC = lamivudine, ddI = didanosine, DRV = darunavir, EFV = efavirenz, FPV = fosamprenavir, FTC = emtricitabine, LPV = lopinavir, NVP = nevirapine, RAL = raltegravir, r = low dose ritonavir, SQV = saquinavir, TDF = tenofovir, ZDV = zidovudine

* Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. December 1, 2009; 1-161. Available at www.aidsinfo.nih.gov/ContentFiles/AdultandAdolescentGL.pdf. Accessed January 25, 2010; page 39; Table 5a




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary
  • PDF PDF

This article was provided by Positively Aware. It is a part of the publication Positively Aware. Visit Positively Aware's website to find out more about the publication.
 
See Also
The 16th Annual HIV Drug Guide

Tools
 

Advertisement